Biogen buys rights to experimental Alzheimer drugs
By Kanoko Matsuyama(Bloomberg) -- Biogen Idec Inc., a maker of multiple sclerosis drugs, has acquired the rights to experimental Alzheimer’s disease treatments from…
February 25, 2014
Too-big-to-fail problem still haunting usThe real policy goal must be ensuring that these institutions can fail like all others -- in a standard bankruptcy process, without the need for government support.
February 24, 2014
Margin Surge Spells TroubleThe stock market's mood can change on the dime. And when things get really out of whack, it's up to the prudent advisor to notice it before it whacks client…
February 24, 2014
Growth and ValueFort Pitt Capital Group started life as the money management division of a brokerage firm in Pittsburgh.
February 24, 2014
The Perfectly Dangerous Thing Your Clients WantWhat a Michelle Pfeiffer photo shoot can teach advisors about their clients.
February 21, 2014
Fed damned every way by emerging market angstYellen says a well-managed U.S. economy benefits the world and other central banks have tools to support their own economies.
February 20, 2014
Swiss Endanger EU Ties With Immigration VoteSwiss opposition to free travel could cost the countrys economy dearly.
February 19, 2014
6 reasons to avoid special needs planningAn agent in the market talks about who should -- and should not -- consider following her in.